S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.12%) $0.928
USD/NOK
(0.14%) $10.86
USD/GBP
(0.01%) $0.792
USD/RUB
(-0.07%) $92.51

Realtime updates for Taiko Pharmaceutical [4574.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated29 Mar 2024 @ 02:15

0.78% ¥ 388.00

Live Chart Being Loaded With Signals

Commentary (29 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF...

Stats
Today's Volume 129 500
Average Volume 506 661
Market Cap 19.46B
EPS ¥0 ( 2024-02-08 )
Next earnings date ( ¥0 ) 2024-05-09
Last Dividend ¥13.00 ( 2021-12-29 )
Next Dividend ¥0 ( N/A )
P/E -7.55
ATR14 ¥0.526 (0.14%)

Volume Correlation

Long: -0.06 (neutral)
Short: 0.60 (weak)
Signal:(45.678) Neutral

Taiko Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Taiko Pharmaceutical Correlation - Currency/Commodity

The country flag -0.02
( neutral )
The country flag -0.27
( neutral )
The country flag -0.35
( neutral )
The country flag 0.37
( neutral )
The country flag 0.60
( weak )
The country flag 0.29
( neutral )

Taiko Pharmaceutical Financials

Annual 2022
Revenue: ¥5.04B
Gross Profit: ¥1.08B (21.41 %)
EPS: ¥-112.24
Q3 2023
Revenue: ¥1.93B
Gross Profit: ¥740.00M (38.36 %)
EPS: ¥0
Q2 2023
Revenue: ¥1.32B
Gross Profit: ¥477.00M (36.11 %)
EPS: ¥-5.76
Q1 2023
Revenue: ¥1.17B
Gross Profit: ¥574.00M (49.19 %)
EPS: ¥-5.57

Financial Reports:

No articles found.

Taiko Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Taiko Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.484 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥0.556 2009-03-26
Last Dividend ¥13.00 2021-12-29
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 18 --
Total Paid Out ¥72.22 --
Avg. Dividend % Per Year 0.00% --
Score 1.18 --
Div. Sustainability Score 0.484
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-15)
¥0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.18
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9543.T Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
8595.T Ex Dividend Junior 2023-03-30 Annually 0 0.00%
7937.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
7186.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
6472.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
5706.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
4536.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3773.T Ex Dividend Junior 2023-03-30 Insufficient data to determine frequency 0 0.00%
3050.T Ex Dividend Junior 2023-08-30 Semi-Annually 0 0.00%
1949.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.3751.500-7.50-10.00[0 - 0.5]
returnOnAssetsTTM-0.1441.200-4.80-5.76[0 - 0.3]
returnOnEquityTTM-0.2611.500-4.01-6.02[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.190.80010.008.00[1 - 3]
quickRatioTTM2.540.80010.008.00[0.8 - 2.5]
cashRatioTTM1.7191.5001.5602.34[0.2 - 2]
debtRatioTTM0.188-1.5006.86-10.00[0 - 0.6]
interestCoverageTTM-85.891.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM02.0000[0 - 30]
freeCashFlowPerShareTTM02.0000[0 - 20]
debtEquityRatioTTM0.305-1.5008.78-10.00[0 - 2.5]
grossProfitMarginTTM0.3941.0006.766.76[0.2 - 0.8]
operatingProfitMarginTTM-0.1271.000-4.55-4.55[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.3840.800-0.775-0.620[0.5 - 2]
Total Score0.484

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-7.611.000-0.8700[1 - 100]
returnOnEquityTTM-0.2612.50-2.58-6.02[0.1 - 1.5]
freeCashFlowPerShareTTM02.0000[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM02.0000[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.06271.500-3.750[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.545

Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators